Erratum: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma (PLoS ONE (2016) 11, 3 (e0151750), 10.1371/journal.pone.0151750)

June Y. Hou, Alicia Rodriguez-Gabin, Leleesha Samaraweera, Rachel Hazan, Gary L. Goldberg, Susan Band Horwitz, Hayley M. McDaid

Research output: Contribution to journal › Article

Original languageEnglish (US)
Article numbere0151750
JournalPLoS One
Volume11
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Mitogen-Activated Protein Kinase Kinases
Chemical activation

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Erratum : Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma (PLoS ONE (2016) 11, 3 (e0151750), 10.1371/journal.pone.0151750). / Hou, June Y.; Rodriguez-Gabin, Alicia; Samaraweera, Leleesha; Hazan, Rachel; Goldberg, Gary L.; Horwitz, Susan Band; McDaid, Hayley M.

In: PLoS One, Vol. 11, No. 3, e0151750, 01.03.2016.

Research output: Contribution to journal › Article

Hou, JY, Rodriguez-Gabin, A, Samaraweera, L, Hazan, R, Goldberg, GL, Horwitz, SB & McDaid, HM 2016, 'Erratum: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma (PLoS ONE (2016) 11, 3 (e0151750), 10.1371/journal.pone.0151750)', PLoS One, vol. 11, no. 3, e0151750. https://doi.org/10.1371/journal.pone.0151750
Hou JY, Rodriguez-Gabin A, Samaraweera L, Hazan R, Goldberg GL, Horwitz SB et al. Erratum: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma (PLoS ONE (2016) 11, 3 (e0151750), 10.1371/journal.pone.0151750). PLoS One. 2016 Mar 1;11(3). e0151750. https://doi.org/10.1371/journal.pone.0151750
Hou, June Y. ; Rodriguez-Gabin, Alicia ; Samaraweera, Leleesha ; Hazan, Rachel ; Goldberg, Gary L. ; Horwitz, Susan Band ; McDaid, Hayley M. / Erratum : Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma (PLoS ONE (2016) 11, 3 (e0151750), 10.1371/journal.pone.0151750). In: PLoS One. 2016 ; Vol. 11, No. 3.
@article{e0feefc496a647459bbad3a2422404aa,
title = "Erratum: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma (PLoS ONE (2016) 11, 3 (e0151750), 10.1371/journal.pone.0151750)",
author = "Hou, {June Y.} and Alicia Rodriguez-Gabin and Leleesha Samaraweera and Rachel Hazan and Goldberg, {Gary L.} and Horwitz, {Susan Band} and McDaid, {Hayley M.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1371/journal.pone.0151750",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Erratum

T2 - Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma (PLoS ONE (2016) 11, 3 (e0151750), 10.1371/journal.pone.0151750)

AU - Hou, June Y.

AU - Rodriguez-Gabin, Alicia

AU - Samaraweera, Leleesha

AU - Hazan, Rachel

AU - Goldberg, Gary L.

AU - Horwitz, Susan Band

AU - McDaid, Hayley M.

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84962510808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962510808&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0151750

DO - 10.1371/journal.pone.0151750

M3 - Article

AN - SCOPUS:84962510808

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0151750

ER -

Access to Document